F
Felix Prinz
Researcher at Medical University of Graz
Publications - 17
Citations - 409
Felix Prinz is an academic researcher from Medical University of Graz. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 7, co-authored 13 publications receiving 220 citations.
Papers
More filters
Journal ArticleDOI
Involvement of the long noncoding RNA NEAT1 in carcinogenesis
TL;DR: The role of NEAT1 function in tumorigenesis suggests it may be a prognostic biomarker as well as potential therapeutic target, pending the completion of further studies into the underlying mechanisms.
Journal ArticleDOI
The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases
TL;DR: NEAT1 expression is aberrantly—mostly upregulated—in non-cancerous pathological conditions, indicating that it could serve as potential prognostic biomarker and additional studies are needed to elucidate NEAT1’s capability to be a therapeutic target for non- cancerous diseases.
Journal ArticleDOI
Current concepts of non-coding RNA regulation of immune checkpoints in cancer
TL;DR: In the present review, interactions between non coding RNAs and immune checkpoint molecules, within the framework of human cancer, will be discussed and current and developing concepts between the immunological and non-coding RNA world will be elucidated.
Journal ArticleDOI
MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2.
Carina Seidl,Katrin Panzitt,Alexandra Bertsch,Luka Brcic,Sandra Schein,Maximilian Mack,Katharina Leithner,Felix Prinz,Horst Olschewski,Karin Kornmueller,Andelko Hrzenjak +10 more
TL;DR: The results indicate that the miR-182-5p/GLI2 axis modulates tumorigenesis and cisplatin-resistance in LADC cells, by influencing the HHSP, and this axis might be considered as a potential biomarker and future therapeutic target in L ADC patients.
Journal ArticleDOI
Long-Noncoding RNA (lncRNA) in the Regulation of Hypoxia-Inducible Factor (HIF) in Cancer
Dominik A. Barth,Dominik A. Barth,Felix Prinz,Julia Teppan,Katharina Jonas,Christiane Klec,Martin Pichler,Martin Pichler +7 more
TL;DR: A comprehensive update and overview of lncRNAs as regulators of HIFs expression and activation and discusses and highlights potential involved pathways is provided.